Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.1B | 9.4B | 10.7B | 10.0B |
Cost of revenue | 8.2B | 8.1B | 8.7B | 8.5B |
Gross profit | -43M | 1.4B | 2.1B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.2B | -2.6B | 1.3B | 1.2B |
Operating income | -707M | 377M | 1.3B | 636M |
Non operating interest income | ||||
Income | 52M | 204M | 57M | 109M |
Expense | 130M | 151M | 146M | 147M |
Other income expense | — | — | — | — |
Pretax income | -883M | 590M | 1.4B | 572M |
Tax provision | -4M | 45M | 240M | 99M |
Net income | -879M | 553M | 1.1B | 473M |
Basic EPS | — | — | 0.9 | 0.4 |
Diluted EPS | — | — | 0.9 | 0.4 |
Basic average shares | — | — | 1.2B | 1.2B |
Diluted average shares | — | — | 1.2B | 1.2B |
EBITDA | -120M | 1.2B | 2.1B | 1.3B |
Net income from continuing op. | -883M | 588M | 1.3B | 572M |
Minority interests | -6M | -3M | -3M | -4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |